Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Thomas J. Errico | Director | 2024-08-15 | 5,000 | $6.12 | $30.60kBuy |
John P. Gandolfo | Director | 2024-06-13 | 1,000 | $6.43 | $6.43kBuy |
Julie Ann Goldstein | Director | 2024-06-05 | 7,701 | $6.43 | $49.52kBuy |
Thomas M. Patton | Director | 2024-06-05 | 7,701 | $6.43 | $49.52kBuy |
Patricia Wilber | Director | 2024-06-05 | 6,931 | $6.43 | $44.57kBuy |
Daniel S. Goldberger | Chief Executive Officer | 2024-06-05 | 38,505 | $6.43 | $247.59kBuy |
Thomas J. Errico | Director | 2024-06-05 | 38,505 | $6.43 | $247.59kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Joseph P. Errico | 53.69% | 3,861,942 | $33.06M | Insider |
Merck Global Health Innovation Fund LLC | 46.52% | 3,346,032 | $28.64M | Insider |
James L. L. Tullis | 28.00% | 2,014,110 | $17.24M | Insider |
Thomas J. Errico | 13.28% | 955,491 | $8.18M | Insider |
Core Ventures II LLC | 8.99% | 646,342 | $5.53M | Insider |
Peter S. Staats | 6.62% | 476,419 | $4.08M | Insider |
Charles Steve Theofilos | 6.43% | 462,758 | $3.96M | Insider |
Francis R. Amato | 5.12% | 368,355 | $3.15M | Insider |
Daniel S. Goldberger | 4.03% | 289,565 | $2.48M | Insider |
Vanguard Group Inc | 2.35% | 168,924 | $1.45M | Institution |